Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning effectiveness of COVID-19 vaccines
Hiam Chemaitelly, Laith J. Abu‐Raddad
The Lancet (2022) Vol. 399, Iss. 10327, pp. 771-773
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Georg M. N. Behrens, Joana Barros‐Martins, Anne Cossmann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Is long COVID the next global health crisis?
Mark A. Faghy, Rebecca Owen, Callum Thomas, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 34
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Elias Tayar, Sami Abdeen, Muna Abed Alah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 2, pp. 250-256
Open Access | Times Cited: 29
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Kunal Nepali, Ram Lal Sharma, Sachin Sharma, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 28
Active Enrichment of Nanoparticles for Ultra-Trace Point-of-Care COVID-19 Detection
Yong Luo, Mengyun Zhou, Chuan Fan, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 12, pp. 5316-5322
Closed Access | Times Cited: 18
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
James T. Gordy, Yinan Hui, Courtney Schill, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The vast majority of SARS-CoV-2 infections were asymptomatic in a clinic-based cohort of people with and without HIV in four African countries
Rither Langat, Natalie Burns, Ibrahim Daud, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
Jing Zou, Chaitanya Kurhade, Hongjie Xia, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Who is “anti-science”?
Élisabeth Paul, Garrett Wallace Brown, Valéry Ridde, et al.
Public Health in Practice (2024) Vol. 7, pp. 100493-100493
Open Access | Times Cited: 4
Molecular and genetic characteristic of some Omicron variants of the SARS-CoV-2 virus and prospects for vaccine prevention of COVID-19
В. І. Задорожна, Н. П. Винник, Anton Gerilovych
One Health Journal (2025) Vol. 3, Iss. I, pp. 5-21
Closed Access
COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves
Roxana Manuela Fericean, Ovidiu Roşca, Cosmin Cîtu, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6803-6803
Open Access | Times Cited: 18
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020–2022
Reshma Kassanjee, Mary‐Ann Davies, Alexa Heekes, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 628-628
Open Access | Times Cited: 3
Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022
Kimberly H. Nguyen, Yingjun Bao, Siyu Chen, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 669-669
Open Access | Times Cited: 3
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
Chayanit Mahasing, Rapeepong Suphanchaimat, Pard Teekasap, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310427-e0310427
Open Access | Times Cited: 3
High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 3, pp. 100156-100156
Open Access | Times Cited: 9
Use of science in public policy: Lessons from the COVID-19 pandemic efforts to ‘Follow the Science’
Barry Bozeman
Science and Public Policy (2022) Vol. 49, Iss. 5, pp. 806-817
Closed Access | Times Cited: 15
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Elias Tayar, Sami Abdeen, Muna Abed Alah, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top